Shcova Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -64.64%
(FY 2023)
- Ebitda -64.64%
(FY 2023)
- Net Worth -0.49%
(FY 2023)
- Total Assets %
(FY 2023)
About Shcova Laboratories
The Corporate was formerly known as Shcova Specialized Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Varma and Shailaja Manohar serve as directors at the Company.
- CIN/LLPIN
U24233MH2012PTC234706
- Company No.
234706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shcova Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Varma  | Director | 21-Aug-2012 | Current |
| Shailaja Manohar | Director | 12-Dec-2013 | Current |
Financial Performance of Shcova Laboratories.
Shcova Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 64.64% decrease in profit. The company's net worth dipped by a decrease of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shcova Laboratories?
In 2023, Shcova Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivan Life Sciences Private LimitedActive 14 years 8 monthsSatish Varma and Shailaja Manohar are mutual person
Apintus Labs Private LimitedActive 9 years 7 monthsSatish Varma and Shailaja Manohar are mutual person
Vivan Advanced Chemicals Lab Private LimitedActive 1 year 5 monthsShailaja Manohar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shcova Laboratories?
Unlock and access historical data on people associated with Shcova Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shcova Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shcova Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
